Eμ-myc mice contain a transgene in which the immunoglobulin heavy chain enhancer is driving expression of the Myc oncogene in the B-lineage cells resulting in the development of B-cell lymphomas [37]. Here, MYC is linked to B-cell non-Hodgkin lymphoma.